Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1069


The Proline 7 Substitution in the Preproneuropeptide Y Is Associated with Higher Hepatic Lipase Activity In Vivo.

Schiekofer S, Kleber ME, Maerz W, Rasche FM, Schneider JG.

Int J Endocrinol. 2017;2017:2869090. doi: 10.1155/2017/2869090. Epub 2017 May 30.


Moderate statin treatment reduces prebeta-1 high-density lipoprotein levels in dyslipidemic patients.

Quinn AG, Schwemberger R, Stock EO, Movsesyan I, Axtell A, Chang S, Ishida BY, Malloy MJ, Kane JP, Pullinger CR.

J Clin Lipidol. 2017 May 4. pii: S1933-2874(17)30256-8. doi: 10.1016/j.jacl.2017.04.118. [Epub ahead of print]


Ginger Treatment Ameliorates Alcohol-induced Myocardial Damage by Suppression of Hyperlipidemia and Cardiac Biomarkers in Rats.

Subbaiah GV, Mallikarjuna K, Shanmugam B, Ravi S, Taj PU, Reddy KS.

Pharmacogn Mag. 2017 Jan;13(Suppl 1):S69-S75. doi: 10.4103/0973-1296.203891. Epub 2017 Apr 7.


The association of eight potentially functional polymorphisms in five adrenergic receptor-encoding genes with myocardial infarction risk in Han Chinese.

Xia K, Ding R, Zhang Z, Li W, Shang X, Yang X, Wang L, Zhang Q.

Gene. 2017 Aug 15;624:43-49. doi: 10.1016/j.gene.2017.04.045. Epub 2017 Apr 27.


Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.

Landray MJ, Reveal Collaborative Group; L. Bowman, F. Chen, E. Sammons, J.C. Hopewell, K. Wallendszus, W. Stevens, E. Valdes-Marquez, S. Wiviott, C.P. Cannon, E. Braunwald, R. Collins, M.J. Landray (Writing Committtee).

Am Heart J. 2017 May;187:182-190. doi: 10.1016/j.ahj.2017.02.021. Epub 2017 Feb 21.


The immunology of atherosclerosis.

Gisterå A, Hansson GK.

Nat Rev Nephrol. 2017 Jun;13(6):368-380. doi: 10.1038/nrneph.2017.51. Epub 2017 Apr 10. Review.


Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.

Khera AV, Won HH, Peloso GM, O'Dushlaine C, Liu D, Stitziel NO, Natarajan P, Nomura A, Emdin CA, Gupta N, Borecki IB, Asselta R, Duga S, Merlini PA, Correa A, Kessler T, Wilson JG, Bown MJ, Hall AS, Braund PS, Carey DJ, Murray MF, Kirchner HL, Leader JB, Lavage DR, Manus JN, Hartzel DN, Samani NJ, Schunkert H, Marrugat J, Elosua R, McPherson R, Farrall M, Watkins H, Lander ES, Rader DJ, Danesh J, Ardissino D, Gabriel S, Willer C, Abecasis GR, Saleheen D, Dewey FE, Kathiresan S; Myocardial Infarction Genetics Consortium, DiscovEHR Study Group, CARDIoGRAM Exome Consortium, and Global Lipids Genetics Consortium.

JAMA. 2017 Mar 7;317(9):937-946. doi: 10.1001/jama.2017.0972.


Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.

Pechlaner R, Tsimikas S, Yin X, Willeit P, Baig F, Santer P, Oberhollenzer F, Egger G, Witztum JL, Alexander VJ, Willeit J, Kiechl S, Mayr M.

J Am Coll Cardiol. 2017 Feb 21;69(7):789-800. doi: 10.1016/j.jacc.2016.11.065.


High-density lipoproteins in high resolution: Will proteomics solve the paradox for cardiovascular risk?

Baig F, Joshi A, Mayr M.

Proteomics. 2017 Feb;17(3-4). doi: 10.1002/pmic.201600426.


HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels.

Annema W, Willemsen HM, de Boer JF, Dikkers A, van der Giet M, Nieuwland W, Muller Kobold AC, van Pelt LJ, Slart RH, van der Horst IC, Dullaart RP, Tio RA, Tietge UJ.

J Clin Lipidol. 2016 Nov - Dec;10(6):1318-1328. doi: 10.1016/j.jacl.2016.08.003. Epub 2016 Aug 17.


The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.

Teng N, Maghzal GJ, Talib J, Rashid I, Lau AK, Stocker R.

Redox Rep. 2017 Mar;22(2):51-73. doi: 10.1080/13510002.2016.1256119. Epub 2016 Nov 25. Review.


Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).

Michael Gibson C, Korjian S, Tricoci P, Daaboul Y, Yee M, Jain P, Alexander JH, Steg PG, Lincoff AM, Kastelein JJ, Mehran R, D'Andrea DM, Deckelbaum LI, Merkely B, Zarebinski M, Ophuis TO, Harrington RA.

Circulation. 2016 Dec 13;134(24):1918-1930. Epub 2016 Nov 15.


L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages.

Yang TC, Chang PY, Lu SC.

Am J Physiol Heart Circ Physiol. 2017 Feb 1;312(2):H265-H274. doi: 10.1152/ajpheart.00509.2016. Epub 2016 Nov 18.


The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.

Rerup SA, Bang LE, Mogensen UM, Engstrøm T, Jørgensen E, Pedersen F, Torp-Pedersen C, Gislason G, James S, Hagström E, Køber L, Fosbøl EL.

Am Heart J. 2016 Nov;181:35-42. doi: 10.1016/j.ahj.2016.08.001. Epub 2016 Aug 10.


Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Nordestgaard BG, Langsted A.

J Lipid Res. 2016 Nov;57(11):1953-1975. Epub 2016 Sep 27. Review.


Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.

Sniderman AD, Islam S, McQueen M, Pencina M, Furberg CD, Thanassoulis G, Yusuf S.

J Am Heart Assoc. 2016 Oct 13;5(10). pii: e003665.


A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus.

Zhang PH, Gao JL, Pu C, Feng G, Wang LZ, Huang LZ, Zhang Y.

Lipids Health Dis. 2016 Aug 30;15:142. doi: 10.1186/s12944-016-0307-3.


Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents.

Khetarpal SA, Schjoldager KT, Christoffersen C, Raghavan A, Edmondson AC, Reutter HM, Ahmed B, Ouazzani R, Peloso GM, Vitali C, Zhao W, Somasundara AV, Millar JS, Park Y, Fernando G, Livanov V, Choi S, Noé E, Patel P, Ho SP; Myocardial Infarction Exome Sequencing Study, Kirchgessner TG, Wandall HH, Hansen L, Bennett EP, Vakhrushev SY, Saleheen D, Kathiresan S, Brown CD, Abou Jamra R, LeGuern E, Clausen H, Rader DJ.

Cell Metab. 2016 Aug 9;24(2):234-45. doi: 10.1016/j.cmet.2016.07.012.

Supplemental Content

Loading ...
Support Center